Nasdaq · CIK 0001671927
IMCR Immunocore Holdings plc
Insider trading from SEC Form 4. Last filing May 28, 2026. Close $29.39 on Oct 9, 2026, +6% from the 52-week low and -27% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
12
with a Form 4 at this company
Price and insider trades, last year
IMCROct 9, 2026 · close 29.39
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Immunocore Holdings plc, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | David M Berman HEAD OF R&D sell | $193k 5,965 shares | -50% | +33% from low-19% from high | |
| 35Weak | John Goll SVP, FINANCE & CAO sell | $23k 698 shares | -52% | +33% from low-19% from high | |
| 50Moderate | Bahija Jallal CHIEF EXECUTIVE OFFICER sell | $371k 11,474 shares | -48% | +33% from low-19% from high | |
| 30Weak | Tina Amber St Leger CHIEF HR OFFICER sell | $32k 1,000 shares | -47% | +33% from low-19% from high | |
| 25Weak | David M Berman HEAD OF R&D sell | $1.3M 31,913 shares | -102% | +64% from low0% from high | |
| 25Weak | David M Berman HEAD OF R&D sell | $3.0M 74,925 shares | -108% | +64% from low0% from high | |
| 21Weak | David M Berman HEAD OF R&D sell | $725k 18,120 shares | -18120% | +58% from low-2% from high | |
| 25Weak | David M Berman HEAD OF R&D sell | $2.2M 61,849 shares | -100% | +48% from low-6% from high | |
| 22Weak | David M Berman HEAD OF R&D sell | $811k 22,732 shares | -101% | +44% from low-9% from high | |
| 25Weak | David M Berman HEAD OF R&D sell | $1.8M 50,419 shares | -161% | +48% from low-6% from high | |
| 50Moderate | Baker Bros. Advisors LP director buy | $24M 807,338 shares | +735% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 17, 2025 | Brian Di Donato affiliate | 100,000 0.20% of outstanding | $3.0M | Mar 17, 2025 | $1.6M |
| Mar 14, 2025 | Brian Di Donato affiliate | 56,250 0.11% of outstanding | $1.6M | Mar 14, 2025 | none |
Transactions
The last 78 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | John Irving Bell director | AGrant or award Share Option (Right to Buy)derivative | +27,492 | $0.00 | $0 | 27,492 | May 28, 2026 |
| Feb 17, 2026 | Tina Amber St Leger CHIEF HR OFFICER | MOption exercise Ordinary Shares | +2,119 | $0.00 | $0 | 2,119 | Feb 19, 2026 |
| Feb 17, 2026 | Bahija Jallal CHIEF EXECUTIVE OFFICER | MOption exercise Ordinary Shares | +23,817 | $0.00 | $0 | 23,817 | Feb 19, 2026 |
| Feb 17, 2026 | John Goll SVP, FINANCE & CAO | MOption exercise Ordinary Shares | +1,351 | $0.00 | $0 | 1,351 | Feb 19, 2026 |
| Feb 17, 2026 | David M Berman HEAD OF R&D | MOption exercise Ordinary Shares | +11,824 | $0.00 | $0 | 11,824 | Feb 19, 2026 |
| Feb 17, 2026 | Travis Alan Coy Chief Financial Officer | AGrant or award Restricted Share Unitsderivative | +33,353 | $0.00 | $0 | 33,353 | Feb 19, 2026 |
| Feb 18, 2026 | David M Berman HEAD OF R&D | SOpen-market sale Ordinary Shares | -5,965 | $32.35 | $193k | 5,859 | Feb 19, 2026 |
| Feb 17, 2026 | Travis Alan Coy Chief Financial Officer | AGrant or award Employee Share Option (Right to Buy)derivative | +95,637 | $0.00 | $0 | 95,637 | Feb 19, 2026 |
| Feb 18, 2026 | Tina Amber St Leger CHIEF HR OFFICER | SOpen-market sale Ordinary Shares | -1,000 | $32.35 | $32k | 1,119 | Feb 19, 2026 |
| Feb 18, 2026 | Bahija Jallal CHIEF EXECUTIVE OFFICER | SOpen-market sale Ordinary Shares | -11,474 | $32.35 | $371k | 12,343 | Feb 19, 2026 |
| Feb 18, 2026 | John Goll SVP, FINANCE & CAO | SOpen-market sale Ordinary Shares | -698 | $32.35 | $23k | 653 | Feb 19, 2026 |
| Feb 17, 2026 | John Goll SVP, FINANCE & CAO | MOption exercise Restricted Share Unitsderivative | -1,351 | $0.00 | $0 | 4,054 | Feb 19, 2026 |
| Feb 17, 2026 | Bahija Jallal CHIEF EXECUTIVE OFFICER | MOption exercise Restricted Share Unitsderivative | -23,817 | $0.00 | $0 | 71,453 | Feb 19, 2026 |
| Feb 17, 2026 | Tina Amber St Leger CHIEF HR OFFICER | MOption exercise Restricted Share Unitsderivative | -2,119 | $0.00 | $0 | 6,357 | Feb 19, 2026 |
| Feb 17, 2026 | David M Berman HEAD OF R&D | MOption exercise Restricted Share Unitsderivative | -11,824 | $0.00 | $0 | 35,473 | Feb 19, 2026 |
| Feb 17, 2026 | John Goll SVP, FINANCE & CAO | AGrant or award Restricted Share Unitsderivative | +7,411 | $0.00 | $0 | 7,411 | Feb 19, 2026 |
| Feb 17, 2026 | Bahija Jallal CHIEF EXECUTIVE OFFICER | AGrant or award Restricted Share Unitsderivative | +88,573 | $0.00 | $0 | 88,573 | Feb 19, 2026 |
| Feb 17, 2026 | John Goll SVP, FINANCE & CAO | AGrant or award Employee Share Option (Right to Buy)derivative | +21,252 | $0.00 | $0 | 21,252 | Feb 19, 2026 |
| Feb 17, 2026 | Bahija Jallal CHIEF EXECUTIVE OFFICER | AGrant or award Employee Share Option (Right to Buy)derivative | +395,066 | $0.00 | $0 | 395,066 | Feb 19, 2026 |
| Dec 4, 2025 | David M Berman HEAD OF R&D | MOption exercise Ordinary Shares10b5-1 | +31,341 | $17.46 | $547k | 31,341 | Dec 8, 2025 |
| Dec 4, 2025 | David M Berman HEAD OF R&D | SOpen-market sale Ordinary Shares10b5-1 | -31,341 | $40.26 | $1.3M | 0 | Dec 8, 2025 |
| Dec 5, 2025 | David M Berman HEAD OF R&D | MOption exercise Ordinary Shares10b5-1 | +572 | $17.46 | $9,987 | 572 | Dec 8, 2025 |
| Dec 5, 2025 | David M Berman HEAD OF R&D | SOpen-market sale Ordinary Shares10b5-1 | -572 | $40.14 | $23k | 0 | Dec 8, 2025 |
| Dec 4, 2025 | David M Berman HEAD OF R&D | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -31,341 | $0.00 | $0 | 12,404 | Dec 8, 2025 |
| Dec 5, 2025 | David M Berman HEAD OF R&D | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -572 | $0.00 | $0 | 11,832 | Dec 8, 2025 |
| Nov 26, 2025 | David M Berman HEAD OF R&D | MOption exercise Ordinary Shares10b5-1 | +69,404 | $17.46 | $1.2M | 69,404 | Dec 1, 2025 |
| Nov 26, 2025 | David M Berman HEAD OF R&D | SOpen-market sale Ordinary Shares10b5-1 | -69,404 | $40.12 | $2.8M | 0 | Dec 1, 2025 |
| Nov 28, 2025 | David M Berman HEAD OF R&D | MOption exercise Ordinary Shares10b5-1 | +5,521 | $17.46 | $96k | 5,521 | Dec 1, 2025 |
| Nov 28, 2025 | David M Berman HEAD OF R&D | SOpen-market sale Ordinary Shares10b5-1 | -5,521 | $40.09 | $221k | 0 | Dec 1, 2025 |
| Nov 26, 2025 | David M Berman HEAD OF R&D | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -69,404 | $0.00 | $0 | 49,266 | Dec 1, 2025 |
| Nov 28, 2025 | David M Berman HEAD OF R&D | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -5,521 | $0.00 | $0 | 43,745 | Dec 1, 2025 |
| Nov 24, 2025 | David M Berman HEAD OF R&D | MOption exercise Ordinary Shares10b5-1 | +100 | $17.46 | $1,746 | 100 | Nov 26, 2025 |
| Nov 24, 2025 | David M Berman HEAD OF R&D | SOpen-market sale Ordinary Shares10b5-1 | -100 | $40.00 | $4,000 | 0 | Nov 26, 2025 |
| Nov 25, 2025 | David M Berman HEAD OF R&D | MOption exercise Ordinary Shares10b5-1 | +18,020 | $17.46 | $315k | 18,020 | Nov 26, 2025 |
| Nov 25, 2025 | David M Berman HEAD OF R&D | SOpen-market sale Ordinary Shares10b5-1 | -18,020 | $40.03 | $721k | 0 | Nov 26, 2025 |
| Nov 24, 2025 | David M Berman HEAD OF R&D | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -100 | $0.00 | $0 | 136,690 | Nov 26, 2025 |
| Nov 25, 2025 | David M Berman HEAD OF R&D | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -18,020 | $0.00 | $0 | 118,670 | Nov 26, 2025 |
| Sep 30, 2025 | David M Berman HEAD OF R&D | MOption exercise Ordinary Shares10b5-1 | +61,849 | $17.46 | $1.1M | 61,849 | Oct 2, 2025 |
| Sep 30, 2025 | David M Berman HEAD OF R&D | SOpen-market sale Ordinary Shares10b5-1 | -61,849 | $35.23 | $2.2M | 0 | Oct 2, 2025 |
| Sep 30, 2025 | David M Berman HEAD OF R&D | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -61,849 | $0.00 | $0 | 136,790 | Oct 2, 2025 |
| Sep 12, 2025 | David M Berman HEAD OF R&D | MOption exercise Ordinary Shares10b5-1 | +22,532 | $17.46 | $393k | 22,532 | Sep 16, 2025 |
| Sep 12, 2025 | David M Berman HEAD OF R&D | SOpen-market sale Ordinary Shares10b5-1 | -21,232 | $35.63 | $756k | 1,300 | Sep 16, 2025 |
| Sep 12, 2025 | David M Berman HEAD OF R&D | SOpen-market sale Ordinary Shares10b5-1 | -1,300 | $36.31 | $47k | 0 | Sep 16, 2025 |
| Sep 15, 2025 | David M Berman HEAD OF R&D | MOption exercise Ordinary Shares10b5-1 | +200 | $17.46 | $3,492 | 200 | Sep 16, 2025 |
| Sep 15, 2025 | David M Berman HEAD OF R&D | SOpen-market sale Ordinary Shares10b5-1 | -200 | $35.01 | $7,002 | 0 | Sep 16, 2025 |
| Sep 12, 2025 | David M Berman HEAD OF R&D | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -22,532 | $0.00 | $0 | 198,839 | Sep 16, 2025 |
| Sep 15, 2025 | David M Berman HEAD OF R&D | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -200 | $0.00 | $0 | 198,639 | Sep 16, 2025 |
| Sep 10, 2025 | David M Berman HEAD OF R&D | MOption exercise Ordinary Shares10b5-1 | +31,338 | $17.46 | $547k | 31,338 | Sep 12, 2025 |
| Sep 10, 2025 | David M Berman HEAD OF R&D | SOpen-market sale Ordinary Shares10b5-1 | -30,138 | $36.12 | $1.1M | 1,200 | Sep 12, 2025 |
| Sep 10, 2025 | David M Berman HEAD OF R&D | SOpen-market sale Ordinary Shares10b5-1 | -1,200 | $36.77 | $44k | 0 | Sep 12, 2025 |
| Sep 11, 2025 | David M Berman HEAD OF R&D | MOption exercise Ordinary Shares10b5-1 | +19,081 | $17.46 | $333k | 19,081 | Sep 12, 2025 |
| Sep 11, 2025 | David M Berman HEAD OF R&D | SOpen-market sale Ordinary Shares10b5-1 | -19,081 | $36.28 | $692k | 0 | Sep 12, 2025 |
| Sep 10, 2025 | David M Berman HEAD OF R&D | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -31,338 | $0.00 | $0 | 240,452 | Sep 12, 2025 |
| Sep 11, 2025 | David M Berman HEAD OF R&D | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -19,081 | $0.00 | $0 | 221,371 | Sep 12, 2025 |
| May 15, 2025 | Peter John Ratcliffe director | AGrant or award Share Option (Right to Buy)derivative | +26,198 | $0.00 | $0 | 26,198 | May 19, 2025 |
| May 15, 2025 | William Pao director | AGrant or award Share Option (Right to Buy)derivative | +26,198 | $0.00 | $0 | 26,198 | May 19, 2025 |
| May 15, 2025 | Kristine Peterson director | AGrant or award Share Option (Right to Buy)derivative | +26,198 | $0.00 | $0 | 26,198 | May 19, 2025 |
| May 15, 2025 | Siddharth Kaul director | AGrant or award Share Option (Right to Buy)derivative | +26,198 | $0.00 | $0 | 26,198 | May 19, 2025 |
| May 15, 2025 | John Irving Bell director | AGrant or award Share Option (Right to Buy)derivative | +26,198 | $0.00 | $0 | 26,198 | May 19, 2025 |
| May 15, 2025 | Baker Bros. Advisors LP director | AGrant or award Non-Qualified Share Option (right to buy)derivativeindirect: See Footnotes | +26,198 | $0.00 | $0 | 26,198 | May 19, 2025 |
| May 15, 2025 | Roy Steven Herbst director | AGrant or award Share Option (Right to Buy)derivative | +26,198 | $0.00 | $0 | 26,198 | May 19, 2025 |
| May 15, 2025 | Baker Bros. Advisors LP director | AGrant or award Non-Qualified Share Option (right to buy)derivativeindirect: See Footnotes | +26,198 | $0.00 | $0 | 26,198 | May 19, 2025 |
| Mar 17, 2025 | Baker Bros. Advisors LP director | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +60,110 | $29.74 | $1.8M | 170,007 | Mar 19, 2025 |
| Mar 17, 2025 | Baker Bros. Advisors LP director | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +646,290 | $29.74 | $19M | 2,051,711 | Mar 19, 2025 |
| Mar 17, 2025 | Baker Bros. Advisors LP director | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +8,589 | $29.56 | $254k | 178,596 | Mar 19, 2025 |
| Mar 17, 2025 | Baker Bros. Advisors LP director | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +92,349 | $29.56 | $2.7M | 2,144,060 | Mar 19, 2025 |
| Mar 17, 2025 | Baker Bros. Advisors LP director | SOpen-market sale 2.5% Convertible Senior Notes due 2030derivativeindirect: See Footnotes | - | $10,533,376.12 | - | 0 | Mar 19, 2025 |
| Mar 17, 2025 | Baker Bros. Advisors LP director | SOpen-market sale 2.5% Convertible Senior Notes due 2030derivativeindirect: See Footnotes | - | $113,252,773.88 | - | 0 | Mar 19, 2025 |
| Feb 25, 2025 | William Pao director | AGrant or award Share Option (Right to Buy)derivative | +24,443 | $0.00 | $0 | 24,443 | Feb 27, 2025 |
| Feb 17, 2025 | David M Berman HEAD OF R&D | AGrant or award Employee Share Option (Right to Buy)derivative | +129,518 | $0.00 | $0 | 129,518 | Feb 19, 2025 |
| Feb 17, 2025 | John Goll SVP, FINANCE & CAO | AGrant or award Employee Share Option (Right to Buy)derivative | +14,802 | $0.00 | $0 | 14,802 | Feb 19, 2025 |
| Feb 17, 2025 | Bahija Jallal CHIEF EXECUTIVE OFFICER | AGrant or award Employee Share Option (Right to Buy)derivative | +405,824 | $0.00 | $0 | 405,824 | Feb 19, 2025 |
| Feb 17, 2025 | Tina Amber St Leger CHIEF HR OFFICER | AGrant or award Employee Share Option (Right to Buy)derivative | +23,212 | $0.00 | $0 | 23,212 | Feb 19, 2025 |
| Feb 17, 2025 | David M Berman HEAD OF R&D | AGrant or award Restricted Share Unitsderivative | +47,297 | $0.00 | $0 | 47,297 | Feb 19, 2025 |
| Feb 17, 2025 | John Goll SVP, FINANCE & CAO | AGrant or award Restricted Share Unitsderivative | +5,405 | $0.00 | $0 | 5,405 | Feb 19, 2025 |
| Feb 17, 2025 | Bahija Jallal CHIEF EXECUTIVE OFFICER | AGrant or award Restricted Share Unitsderivative | +95,270 | $0.00 | $0 | 95,270 | Feb 19, 2025 |
| Feb 17, 2025 | Tina Amber St Leger CHIEF HR OFFICER | AGrant or award Restricted Share Unitsderivative | +8,476 | $0.00 | $0 | 8,476 | Feb 19, 2025 |
| Jan 1, 2025 | Travis Alan Coy Chief Financial Officer | AGrant or award Employee Share Option (Right to Buy)derivative | +274,033 | $0.00 | $0 | 274,033 | Jan 3, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Baker Bros. Advisors LPdirector, owner, other
- John Irving Belldirector
- David M BermanHEAD OF R&D
- Travis Alan CoyChief Financial Officer
- John GollSVP, FINANCE & CAO
- Roy Steven Herbstdirector
- Bahija JallalCHIEF EXECUTIVE OFFICER
- Siddharth Kauldirector
- William Paodirector
- Kristine Petersondirector
- Peter John Ratcliffedirector
- Tina Amber St LegerCHIEF HR OFFICER
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.